MAGT1 and central nervous system cancer: Given the aforementioned evidence, we proposed a hypothesis that MAGT1 in glioma may regulate the ERK/MAPK signaling pathway and the expression of PD-L1, by which mechanism radioresistance of glioma cells may be affected.